Chinese Journal of Pharmacovigilance ›› 2017, Vol. 14 ›› Issue (3): 169-175.

• Orginal Article • Previous Articles     Next Articles

Overview of the Japanese Drug Clinical Trials Review Mechanism and Its Enlightenment to China

WEI Fen-fang, SUN Yu-xin, CHEN Jian-gang, YANG Yue*   

  1. College of Business Administration, Shenyang Pharmaceutical University, Liaoning Shenyang 110016, China
  • Received:2017-04-20 Revised:2017-04-20 Online:2017-03-20 Published:2017-04-20

Abstract: Objective To introduce the general situation of the examination mechanism of Japanese drug clinical trial and put forward some preliminary suggestions for the review of the mechanism of drug clinical trial in China. Methods The relevant laws and regulations of Japanese drug clinical trials were reviewed, and the differences between Japanese and Chinese drug clinical trial review mechanism were studied by literature research and comparative method. Results &Conclusion By comparing, it was found that the Japanese clinical trial review was divided into the main review process and the corresponding supporting mechanism. This management mechanism can speed up the review of the Japanese drug market speed and reduce the administrative burden, it is worth our reference.

Key words: drug, clinical trial, subject

CLC Number: